Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Herzig

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Seminars in Oncology|June 1, 1985
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiationR H Herzig, P F Coccia, H M Lazarus, et al.
Blood|June 1, 1992
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaA J Barrett, M M Horowitz, R C Ash, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Blood|August 1, 1989
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survivalA J Barrett, M M Horowitz, R P Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
The New England Journal of Medicine|June 14, 1984
Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrowG L Phillips, R H Herzig, H M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Seminars in Oncology|June 1, 1985
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiationR H Herzig, P F Coccia, H M Lazarus, et al.
Blood|June 1, 1992
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaA J Barrett, M M Horowitz, R C Ash, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Blood|August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancyR A Brown, R H Herzig, S N Wolff, et al.
Blood|August 1, 1989
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survivalA J Barrett, M M Horowitz, R P Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's diseaseD E Reece, M J Barnett, J M Connors, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Allogeneic marrow transplantation for refractory Hodgkin's diseaseG L Phillips, D E Reece, M J Barnett, et al.
Pageof 10